Literature DB >> 34760440

Doppler assessment of the ductus venosus and the tricuspid valve at 11-13+6 weeks: Reference ranges and development of sonographic quality assurance standards.

Vanessa Pincham1,2, Jon Hyett3,4, Karen Pollard2, Philip Schluter5, Andrew McLennan1,4.   

Abstract

OBJECTIVE: To develop reference ranges for the ductus venosus (DV) and tricuspid valve (TV) waveforms at 11-14 weeks and define auditable standards to assess operator measurement performance.
MATERIALS AND METHODS: A single operator prospectively obtained quantitative measurements of a number of DV and TV Doppler indices to develop medians and 90% reference intervals (RIs). Measurement agreement studies between two experienced operators were also performed. The measurement bias of three additional operators was subsequently assessed using the newly defined auditable standards.
RESULTS: Doppler measurements were obtained in 292 patients (DV) and 321 patients (TV). Reference ranges were constructed for DV pulsatility index for veins (PIV) which did not change over gestation (mean 1.06; 90% RI 0.86-1.23) and for the TV E-A ratio reference range which was positively correlated with gestation. Measurement agreement studies on 30 additional patients showed the within-operator agreement was almost perfect for DV PIV (ICC, intraclass correlation 0.82-0.86) and strong for TV E-A ratio (ICC 0.68-0.78) while the between-operator agreement was good for both DV PIV and TV E-A ratio measurements (ICC 0.46 for both). DISCUSSION: Development of local reference ranges enabled the definition of quantitative auditable standards that can be utilised in assessment of operator training and ongoing Doppler measurement quality assurance. Measurements of DV PIV and TV E-A ratio by experienced operators were found to be reproducible.
© 2016 Australasian Society for Ultrasound in Medicine.

Entities:  

Keywords:  audit; ductus venosus; first trimester; quality assurance; training; tricuspid valve; ultrasound

Year:  2016        PMID: 34760440      PMCID: PMC8409452          DOI: 10.1002/ajum.12000

Source DB:  PubMed          Journal:  Australas J Ultrasound Med        ISSN: 1836-6864


  29 in total

1.  Auditing ultrasound assessment of fetal nuchal translucency thickness: a review of Australian National Data 2002-2008.

Authors:  Debbie L Nisbet; Ann C Robertson; Philip J Schluter; Andrew C McLennan; Jon A Hyett
Journal:  Aust N Z J Obstet Gynaecol       Date:  2010-10       Impact factor: 2.100

2.  Fetal tricuspid valve Doppler at 11-13 weeks and 6 days: reference values and reproducibility.

Authors:  Milena Almeida Prado Ninno; Adolfo Wenjaw Liao; Clarissa Oliveira Lamberty; Javier Miguelez; Marcelo Zugaib
Journal:  Prenat Diagn       Date:  2010-08       Impact factor: 3.050

3.  Ductus venosus Doppler velocimetry in the first trimester: a new finding.

Authors:  L S Teixeira; J Leite; M J B C Viegas; M M L Faria; A S Chaves; R C Teixeira; M C Pires; H Pettersen
Journal:  Ultrasound Obstet Gynecol       Date:  2008-03       Impact factor: 7.299

Review 4.  Promises and pitfalls of first trimester sonographic markers in the detection of fetal aneuploidy.

Authors:  Antoni Borrell
Journal:  Prenat Diagn       Date:  2009-01       Impact factor: 3.050

5.  A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation.

Authors:  Nerea Maiz; David Wright; Ana Fatima A Ferreira; Argyro Syngelaki; Kypros H Nicolaides
Journal:  Fetal Diagn Ther       Date:  2012-05-17       Impact factor: 2.587

6.  Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects.

Authors:  Susana Pereira; Ramesh Ganapathy; Argyro Syngelaki; Nerea Maiz; Kypros H Nicolaides
Journal:  Obstet Gynecol       Date:  2011-06       Impact factor: 7.661

7.  Fetal nuchal translucency test for Down's syndrome.

Authors:  G Monni; M A Zoppi; R M Ibba; M Floris
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

8.  UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.

Authors:  R J Snijders; P Noble; N Sebire; A Souka; K H Nicolaides
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

9.  Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.

Authors:  K O Kagan; C Valencia; P Livanos; D Wright; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2009-01       Impact factor: 7.299

10.  Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.

Authors:  Nerea Maiz; Catalina Valencia; Edoho E Emmanuel; Ismini Staboulidou; Kypros H Nicolaides
Journal:  Obstet Gynecol       Date:  2008-09       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.